Researchers are developing a promising alternative to antibiotic treatment for infections caused by Klebsiella pneumoniae bacteria resistant to carbapenem antibiotics. The approach uses antibodies to...
TGV Therapeutics, the pharmaceutical company developing first-in-class drugs for fighting antibiotic-resistant infections, announced it is working with the National Institutes of Health to expand its research...
A team of investigators has found that the mcr-1 drug resistance gene, which encodes resistance to a drug that is used as a last resort, has been found for the first time in Shigella flexneri. Shigella are...
Herpes of the eye, or ocular herpes, is a recurring viral infection that’s usually caused by the herpes simplex virus-1 (HSV-1). This is the same virus that causes cold sores. Ocular herpes can also...
The Food and Drug Administration (FDA) is advising caution before prescribing the antibiotic clarithromycin (Biaxin) to patients with heart disease because of a potential increased risk of heart problems...
The genetic cause behind a strain of typhoid’s resistance to five classes of antibiotics has been uncovered by scientists at the Wellcome Sanger Institute and their collaborators at Public Health...
Novartis and the Bill & Melinda Gates Foundation have formed an alliance to advance development of Novartis’ drug candidate KDU731 for the treatment of cryptosporidiosis. Diarrheal diseases are...
The Lancet has published a new study led by Oriol Mitjà, first author and researcher at the Barcelona Institute for Global Health (ISGlobal), a centre supported by the “la Caixa” Foundation,...
Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at Queen Mary University of London and Newcastle University.
The research, published today in the British...
Wilmington, MA pharmaceutical company, CutisPharma announced today that the US Food and Drug Administration (FDA) has approved FIRVANQ™ (vancomycin hydrochloride) for oral solution, for the treatment...
